Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Clinical trial NCT04192487 · COMPLETED

Trial details

NCT number: NCT04192487
Sponsor: Napo Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome Healthy Volunteers HIV/AIDS HIV Diarrhea Human Immunodeficiency Virus

Start date: 2019-10-22
Primary completion: 2021-08-31
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.